2024 study in Nature links Fusobacterium nucleatum, a common oral bacterium, to 50% of treatment-resistant colorectal cancer cases, potentially leading to new treatments and screening methods.
A study published in Nature suggests a link between a common oral bacterium, Fusobacterium nucleatum, and treatment-resistant colorectal cancer. Researchers discovered that this bacterium was present in 50% of tumors, potentially shielding tumor cells from cancer-fighting drugs. This finding could lead to new treatments and screening methods for colorectal cancer, which is the second-leading cause of cancer deaths in the U.S., with over 53,000 deaths expected in 2024.
March 21, 2024
15 Articles